Lumos Diagnostics Holdings Limited
ASX:LDX.AX
Overview | Financials
Company Name | Lumos Diagnostics Holdings Limited |
Symbol | LDX.AX |
Currency | AUD |
Price | 0.034 |
Market Cap | 28,097,066 |
Dividend Yield | 0% |
52-week-range | 0.028 - 0.108 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Douglas Ward |
Website | https://lumosdiagnostics.com |
An error occurred while fetching data.
About Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD